Erika Hamilton, Chair, Executive Committee, Breast and Breast Program Lead at Sarah Cannon Research Institute, shared a post by Maggie Shaw, Lead Editor at MJH Life Sciences on LinkedIn:
“Love this article about Skip Burris, MD and his legacy following his retirement. He has been instrumental in so many of our careers, touched the lives of so many patients not only directly but through drug development as well.
Hard to summarize a larger-than-life guy like skip into words, but this article by Maggie Shaw does a darn good job!”
Quoting Maggie Shaw‘s post:
“After a storied career at Sarah Cannon Research Institute, Skip Burris, MD, leaves behind a legacy that has fundamentally transformed cancer research. But for those who know him, his impact is measured in more than just data and approvals. In my interview with him for the February issue of Evidence-Based Oncology, part of the AJMC – The American Journal of Managed Care and MJH Life Sciences family, Dr. Burris reflects on a career defined by 3 core words: Kindness, compassion, gratitude.
Here are a few powerful takeaways from his journey:
- Bringing Innovation to the Community: Dr. Burris challenged the status quo by moving clinical trials out of academic centers and into the neighborhoods where patients actually live.
- The Power of Relationships: Whether mentoring young physicians or giving his personal phone number to patients, he believes oncology research is built on personal connectivity and trust.
- A Foundation of Service: His training at the United States Military Academy at West Point and Brooke Army Medical Center grounded his patient-centered approach, emphasizing that “innovation only matters if it improves care for patients in the real world.”
- A Timeless Reminder: “Be kind to the person you’re talking to, because you have no idea what battles they’re currently going through.”
As he passes the leadership baton to David R. Spigel, MD; Vivek Subbiah, MD; Erika Hamilton, MD, FASCO, and Melissa Johnson, Dr. Burris remains a steadfast advocate for protecting public trust in evidence-based medicine and keeping the patient at the center of every discovery.”
Other articles featuring Erika Hamilton on OncoDaily.